Filing Details
- Accession Number:
- 0001633970-15-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 21:01:16
- Reporting Period:
- 2015-02-13
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 21:01:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612229 | Stephen Leonard | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-13 | 2,508 | $10.71 | 25,758 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-13 | 1,508 | $28.34 | 24,250 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-13 | 1,000 | $28.34 | 23,250 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase common stock | Acquisiton | 2015-02-13 | 2,508 | $0.00 | 2,508 | $10.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
137,492 | 2010-10-23 | 2019-10-23 | No | 4 | M | Direct |
Footnotes
- Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
- These shares were sold in multiple transactions at prices ranging from $28.25 to $28.72, inclusive. The reporting person undertakes to provide to Catalent, Inc., any security holder of Catalent, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On October 23, 2009, the reporting person was granted an option to purchase 140,000 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010.